ArticleJournal of veterinary emergency and critical care (San Antonio, Tex. : 2001)
Intravenous Administration of Vitamin K1 in Dogs and Cats Presented for Anticoagulant Rodenticide Poisoning: A Retrospective Study of 58 Cases.
Article in Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Intravenous Administration of Vitamin K1 in Dogs and Cats Presented for Anticoagulant Rodenticide Poisoning: A Retrospective Study of 58 Cases.Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the safety of IV lecithin-solubilizing agent-based vitamin K1 (VK-LSE) administration and compare the outcomes in dogs and cats with anticoagulant rodenticide (AR) poisoning that received IV VK-LSE with or without exogenous coagulation factors (CF).
designRetrospective study (January 2010 to January 2022).
settingUniversity teaching hospital. ANIMALS: Forty-seven dogs and 11 cats.
interventionsNone. MEASUREMENTS AND MAIN
resultsMedical records from dogs and cats diagnosed with AR poisoning were reviewed. Fifty-eight patients received VK-LSE (5 mg/kg, IV). Two groups, animals that received VK-LSE without CF (VK group) and animals that received VK-LSE and CF (VK-CF group), were identified. No adverse effects were recorded after IV VK-LSE administration. Twenty-nine of 58 patients received exogenous CF. No patient received fresh frozen plasma. All patients had coagulation times within reference intervals by 24 h following admission. There was no difference in survival to discharge for dogs (96% VK vs. 85% VK-CF, p = 0.22) or for cats (100%, both groups) between groups.
conclusionIV administration of VK-LSE appears to be safe, with no reported adverse effects. In AR-poisoned dogs and cats, IV VK-LSE administration without exogenous CF appears to rapidly normalize coagulation times, with high survival rates and short hospitalization lengths.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.